• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factorial Validity and Invariance of the 7-Item Generalized Anxiety Disorder Scale (GAD-7) Among Populations With and Without Self-Reported Psychiatric Diagnostic Status.在有和没有自我报告精神科诊断状态的人群中,7项广泛性焦虑障碍量表(GAD-7)的因子效度和不变性
Front Psychol. 2018 Sep 19;9:1741. doi: 10.3389/fpsyg.2018.01741. eCollection 2018.
2
Factorial validity and invariance of the Patient Health Questionnaire (PHQ)-9 among clinical and non-clinical populations.患者健康问卷(PHQ-9)在临床和非临床人群中的因子有效性和不变性。
PLoS One. 2018 Jul 19;13(7):e0199235. doi: 10.1371/journal.pone.0199235. eCollection 2018.
3
Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale (GAD-7) in an Italian coronary heart disease population.7 项广泛性焦虑障碍量表(GAD-7)在意大利冠心病人群中的心理测量特性和测量不变性。
J Affect Disord. 2023 Aug 1;334:213-219. doi: 10.1016/j.jad.2023.04.140. Epub 2023 May 5.
4
Assessing anxiety symptom severity in Rwandese adolescents: cross-gender measurement invariance of GAD-7.评估卢旺达青少年的焦虑症状严重程度:广泛性焦虑障碍量表-7(GAD-7)的跨性别测量不变性
Front Psychiatry. 2024 Mar 11;15:1346267. doi: 10.3389/fpsyt.2024.1346267. eCollection 2024.
5
Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample.在挪威精神病门诊患者样本中,患者健康问卷 9 项版和广泛性焦虑障碍量表 7 项版的因子结构、测量不变性和同时效度。
BMC Psychiatry. 2022 Jul 11;22(1):461. doi: 10.1186/s12888-022-04101-z.
6
The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study.广泛性焦虑障碍和重度抑郁症的潜在结构及共病模式:一项全国性研究。
Depress Anxiety. 2014 Mar;31(3):214-22. doi: 10.1002/da.22139. Epub 2013 Jun 14.
7
Measurement invariance of the GAD-5 Generalized Anxiety Disorder Scale in a Mexican general population sample.墨西哥普通人群样本中广泛性焦虑障碍量表(GAD-5)的测量不变性
Front Psychiatry. 2022 Oct 10;13:973134. doi: 10.3389/fpsyt.2022.973134. eCollection 2022.
8
Factorial invariance of the Patient Health Questionnaire and Generalized Anxiety Disorder Questionnaire.患者健康问卷和广泛性焦虑症问卷的因子不变性。
Br J Clin Psychol. 2013 Nov;52(4):438-49. doi: 10.1111/bjc.12028. Epub 2013 Aug 20.
9
Factorial invariance of a computerized version of the GAD-7 across various demographic groups and over time in primary care patients.在初级保健患者中,经过一段时间,广泛性焦虑障碍 7 项量表(GAD-7)的计算机版本在不同人口统计学群体中的因子不变性。
J Affect Disord. 2019 Jun 1;252:114-121. doi: 10.1016/j.jad.2019.04.032. Epub 2019 Apr 9.
10
Diagnostic utility of worry and rumination: a comparison between generalized anxiety disorder and major depressive disorder.担忧和反刍在诊断中的效用:广泛性焦虑障碍与重性抑郁障碍的比较。
Psychiatry Clin Neurosci. 2014 Sep;68(9):712-20. doi: 10.1111/pcn.12193. Epub 2014 Jun 9.

引用本文的文献

1
Mental health of youth athletes during the second year of the COVID-19 pandemic in Japan: A three-wave cross-sectional study.日本新冠疫情第二年青少年运动员的心理健康:一项三波横断面研究。
PCN Rep. 2025 Aug 16;4(3):e70187. doi: 10.1002/pcn5.70187. eCollection 2025 Sep.
2
Psychometric Properties of the GAD-7 among College Students: Reliability, Validity, Factor Structure, and Measurement Invariance.大学生中广泛性焦虑障碍量表-7(GAD-7)的心理测量特性:信度、效度、因子结构和测量不变性
Transl Issues Psychol Sci. 2023 Dec 14. doi: 10.1037/tps0000382.
3
Clinical utility of the GAD-7 for detecting generalized anxiety in Quechua indigenous people.广泛性焦虑障碍量表-7(GAD-7)在检测克丘亚族原住民广泛性焦虑方面的临床效用。
Front Psychiatry. 2025 May 30;16:1565895. doi: 10.3389/fpsyt.2025.1565895. eCollection 2025.
4
Self-stigma among people with epilepsy: Comparison between Germany and Japan.癫痫患者的自我污名化:德国与日本的比较。
Epilepsia Open. 2025 Jun;10(3):682-693. doi: 10.1002/epi4.70005. Epub 2025 Mar 24.
5
Internal Validity and Reliability of the GAD-7 Test in Latin America.广泛性焦虑障碍7项量表(GAD-7)测试在拉丁美洲的内部效度和信度
Chronic Stress (Thousand Oaks). 2025 Mar 11;9:24705470251315260. doi: 10.1177/24705470251315260. eCollection 2025 Jan-Dec.
6
Risk and Loss Aversion and Attitude to COVID and Vaccines in Anxious Individuals.焦虑个体对新冠病毒及疫苗的风险与损失厌恶及态度
Comput Psychiatr. 2025 Feb 7;9(1):23-38. doi: 10.5334/cpsy.115. eCollection 2025.
7
Identification of unmet information needs among families of critically ill patients and their association with post-intensive care syndrome-family: protocol for a single-center cross-sectional study.识别重症患者家属未满足的信息需求及其与重症监护后综合征-家庭的关联:一项单中心横断面研究方案
BMC Palliat Care. 2025 Jan 29;24(1):29. doi: 10.1186/s12904-024-01599-w.
8
Improving Mental Health and Well-Being Through the Paradym App: Quantitative Study of Real-World Data.通过Paradym应用程序改善心理健康和幸福感:真实世界数据的定量研究
JMIR Form Res. 2025 Jan 23;9:e68031. doi: 10.2196/68031.
9
Efficacy and Safety of Switching between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature Review.抗降钙素基因相关肽单克隆抗体之间转换的疗效与安全性:一项详细的月度及长期随访研究与文献综述
Intern Med. 2025 Jul 15;64(14):2114-2123. doi: 10.2169/internalmedicine.4360-24. Epub 2025 Jan 3.
10
Different effects of migraine associated features on headache impact, pain intensity, and psychiatric conditions in patients with migraine.偏头痛相关特征对偏头痛患者头痛影响、疼痛强度和精神状况的不同影响。
Sci Rep. 2024 Sep 30;14(1):22611. doi: 10.1038/s41598-024-74253-3.

本文引用的文献

1
Diagnostic Validity of the Generalized Anxiety Disorder - 7 (GAD-7) among Pregnant Women.广泛性焦虑障碍量表(GAD-7)在孕妇中的诊断效度
PLoS One. 2015 Apr 27;10(4):e0125096. doi: 10.1371/journal.pone.0125096. eCollection 2015.
2
Assessing depression related severity and functional impairment: the Overall Depression Severity and Impairment Scale (ODSIS).评估与抑郁症相关的严重程度和功能损害:总体抑郁严重程度和损害量表(ODSIS)。
PLoS One. 2015 Apr 13;10(4):e0122969. doi: 10.1371/journal.pone.0122969. eCollection 2015.
3
Validity and clinical interpretability of Overall Anxiety Severity And Impairment Scale (OASIS).总体焦虑严重程度和功能损害量表(OASIS)的效度及临床可解释性。
J Affect Disord. 2015 Jan 1;170:217-24. doi: 10.1016/j.jad.2014.08.045. Epub 2014 Sep 3.
4
Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample.超越广泛性焦虑障碍:GAD-7 在异质精神科样本中的心理测量特性。
J Anxiety Disord. 2014 Aug;28(6):547-52. doi: 10.1016/j.janxdis.2014.06.002. Epub 2014 Jun 14.
5
Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.癫痫患者广泛性焦虑障碍 7 项量表的验证:MEPSY 研究。
Epilepsy Behav. 2014 Jun;35:59-63. doi: 10.1016/j.yebeh.2014.04.005. Epub 2014 May 4.
6
Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study.使用广泛性焦虑症-7量表(GAD-7)和广泛性焦虑症-2量表(GAD-2)评估老年人的广泛性焦虑症:一项效度研究的结果
Am J Geriatr Psychiatry. 2014 Oct;22(10):1029-38. doi: 10.1016/j.jagp.2013.01.076. Epub 2013 Jun 12.
7
Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample.广泛性焦虑障碍 7 项量表在急性精神病样本中的有效性。
Clin Psychol Psychother. 2013 Sep-Oct;20(5):456-64. doi: 10.1002/cpp.1802. Epub 2012 May 17.
8
Establishing measurement invariance: English and Spanish Paediatric Asthma Quality of Life Questionnaire.建立测量不变性:儿童哮喘生活质量问卷的英文和西班牙文版本。
Nurs Res. 2012 May-Jun;61(3):171-80. doi: 10.1097/NNR.0b013e3182544750.
9
How successful are physicians in eliciting the truth from their patients? A large-scale Internet survey from patients' perspectives.医生从患者那里获取真实信息的成功率有多高?一项基于患者视角的大规模互联网调查。
J Clin Psychiatry. 2012 Mar;73(3):311-7. doi: 10.4088/JCP.11m07078.
10
Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment.简短的焦虑障碍筛查工具:GAD-7 和 GAD-2 在成瘾治疗中的验证。
Drug Alcohol Depend. 2012 Sep 1;125(1-2):37-42. doi: 10.1016/j.drugalcdep.2012.03.011. Epub 2012 Apr 4.

在有和没有自我报告精神科诊断状态的人群中,7项广泛性焦虑障碍量表(GAD-7)的因子效度和不变性

Factorial Validity and Invariance of the 7-Item Generalized Anxiety Disorder Scale (GAD-7) Among Populations With and Without Self-Reported Psychiatric Diagnostic Status.

作者信息

Doi Satomi, Ito Masaya, Takebayashi Yoshitake, Muramatsu Kumiko, Horikoshi Masaru

机构信息

Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.

National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan.

出版信息

Front Psychol. 2018 Sep 19;9:1741. doi: 10.3389/fpsyg.2018.01741. eCollection 2018.

DOI:10.3389/fpsyg.2018.01741
PMID:30283386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6157449/
Abstract

The 7-item Generalized Anxiety Disorder Scale (GAD-7) is commonly used to monitor anxiety symptoms. However, its factor structure has been inconsistent among competing models: unidimensional, two-dimensional, or higher order models. Additionally, it is unknown whether the scale has measurement invariance between populations with and without self-reported psychiatric diagnostic status. Participants were Japanese adults with self-reported anxiety disorder (AD; = 479), self-reported AD and major depressive disorder (MDD; = 314), or without self-reported psychiatric diagnostic status (self-reported non-MDD/AD; = 654), who completed this questionnaire on the Internet. Confirmatory factor analyses showed the higher order model had similar fit indices to the unidimensional and two-dimensional factor models. For the higher order model of GAD-7, metric invariance was supported between the self-reported non-MDD/AD and self-reported AD status groups, and scalar invariance was supported between the self-reported AD status and self-reported AD with MDD status groups. Moreover, convergent and discriminant validity were consistent with previous findings in Western cultures. These results suggest that factor loadings are equivalent and the construct has the same meaning between the self-reported non-MDD/AD and self-reported AD status groups, and the total or sub-scale scores were comparable between self-reported AD status and self-reported AD with MDD status groups. The major limitation of this study is that the participants' diagnoses were self-reported, not confirmed by clinical structured interview. Further studies that incorporate clinical structured interviews are needed.

摘要

7项广泛性焦虑障碍量表(GAD-7)常用于监测焦虑症状。然而,在不同的竞争模型中,其因子结构并不一致:一维模型、二维模型或高阶模型。此外,该量表在有和没有自我报告精神科诊断状态的人群之间是否具有测量不变性尚不清楚。参与者为日本成年人,他们通过互联网完成了这份问卷,其中包括自我报告患有焦虑症(AD;n = 479)、自我报告患有AD和重度抑郁症(MDD;n = 314)或没有自我报告精神科诊断状态(自我报告非MDD/AD;n = 654)的人群。验证性因子分析表明,高阶模型与一维和二维因子模型具有相似的拟合指数。对于GAD-7的高阶模型,在自我报告非MDD/AD和自我报告AD状态组之间支持度量不变性,在自我报告AD状态和自我报告AD合并MDD状态组之间支持标量不变性。此外,收敛效度和区分效度与西方文化中的先前研究结果一致。这些结果表明,在自我报告非MDD/AD和自我报告AD状态组之间,因子载荷是等效的,且结构具有相同的含义,并且在自我报告AD状态和自我报告AD合并MDD状态组之间,总分或子量表得分具有可比性。本研究的主要局限性在于参与者的诊断是自我报告的,未经临床结构化访谈确认。需要进一步开展纳入临床结构化访谈的研究。